Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia

Author:

Haeusler Gabrielle M12345,De Abreu Lourenco Richard6,Clark Hannah4,Thursky Karin A12378,Slavin Monica A12379,Babl Franz E101112,Mechinaud Francoise13,Alvaro Frank14,Clark Julia15,Padhye Bhavna16,Phillips Marianne17,Super Leanne18,Tapp Heather19,Walwyn Thomas17,Ziegler David20,Phillips Robert21,Worth Leon J123

Affiliation:

1. Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia

2. National Health and Medical Research Council, National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

3. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

4. Paediatric Integrated Cancer Service, Victoria State Government, Melbourne, Australia

5. Infection Diseases Unit, Department of General Medicine, Royal Children’s Hospital, Melbourne, Australia

6. Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Australia

7. Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

8. NHMRC, National Centre for Antimicrobial Stewardship, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

9. Victorian Infectious Diseases Service, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

10. Murdoch Children’s Research Institute, Melbourne, Australia

11. Department of Emergency Medicine, Royal Children’s Hospital, Melbourne, Australia

12. Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia

13. Unité d’hématologie immunologie pédiatrique, Hopital Robert Debré, APHP Nord Université de Paris, Paris, France

14. Children’s Cancer Department, John Hunter Children’s Hospital, University of Newcastle, Newcastle, Australia

15. Infection Management Service, Queensland Children’s Hospital, Children’s Health Queensland Hospital and Health Service, Brisbane, Australia

16. Kid’s Cancer Centre, Westmead Children’s Hospital, Sydney, Australia

17. Department of Oncology, Perth Children’s Hospital, Perth, Australia

18. Children’s Cancer Centre, Monash Children’s Hospital, Monash Health, Melbourne, Australia

19. Department of Oncology, Women’s and Children’s Hospital, Adelaide, Australia

20. Kid’s Cancer Centre, Sydney Children’s Hospital, Sydney, Australia

21. Centre for Reviews and Dissemination, University of York, York, United Kingdom

Abstract

Abstract Background The timing and necessity of repeated blood cultures (BCs) in children with cancer and febrile neutropenia (FN) are unknown. We evaluated the diagnostic yield of BCs collected pre- and post-empiric FN antibiotics. Methods Data collected prospectively from the Australian Predicting Infectious ComplicatioNs in Children with Cancer (PICNICC) study were used. Diagnostic yield was calculated as the number of FN episodes with a true bloodstream infection (BSI) detected divided by the number of FN episodes that had a BC taken. Results A BSI was identified in 13% of 858 FN episodes. The diagnostic yield of pre-antibiotic BCs was higher than of post-antibiotic cultures (12.3% vs 4.4%, P < .001). Two-thirds of the post-antibiotic BSIs were associated with a new episode of fever or clinical instability, and only 2 new BSIs were identified after 48 hours of empiric antibiotics and persistent fever. A contaminated BC was identified more frequently in post-antibiotic cultures. Conclusions In the absence of new fever or clinical instability, BCs beyond 48 hours of persistent fever have limited yield. Opportunity exists to optimize BC collection in this population and reduce the burden of unnecessary tests on patients, healthcare workers, and hospitals.

Funder

National Health and Medical Research Council

Victorian Cancer Agency

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology, and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3